Melissa Duheric

Dr. Melissa Duheric

orcid

Research Focus & Metrics

Representative Publications

View All Publications
24 March 2025
Verified
Conference Paper
Open access
LALeif Azzopardi
Leif Azzopardi
ENEmma Nicol
Emma Nicol
JBJo Briggs
Jo Briggs
WMWendy Moncur
Wendy Moncur
BSBurkhard Schafer
Burkhard Schafer
MDMelissa Duheric
Melissa Duheric

22 January 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
ABAnna Bertelli
Anna Bertelli
MUMATTEO UGGERI
MATTEO UGGERI
FFFederica Filippini
Federica Filippini
MDMelissa Duheric
Melissa Duheric
FCFrancesca Caccuri
Francesca Caccuri
ACArnaldo Caruso
Arnaldo Caruso
The U94 protein of Human Herpesvirus 6 exerts antiproliferative effects through downregulation of the Src proto-oncogene. We aimed to define the shortest U94 fragment that preserves antiproliferative activity and to explore its structural properties. U94 was truncated into shorter fragments, which were subjected to computational analyses and proliferation assays on MDA-MB-468, BT-549 breast cancer cells. Src phosphorylation levels were scrutinized by Western blot analysis. Data obtained demonstrated that the U94 antiproliferative activity resides in its N-terminal region. Specifically, MT153 (aa 1–153) and MT117 (aa 1–117) fragments exhibited antiproliferative activity, whereas MV85 (aa 1–85) fragment did not. Computational analyses identified MG112 (aa 1–112) and MI108 (aa 1–108) as biologically active and suggested that the β-sheet of the structure is critical. The shortest KI95 fragment (aa 14–108), maintaining a stable β-sheet, demonstrated antiproliferative effects and Src downregulation. The antiproliferative activity of U94 and its active fragments relies on stable tridimensional conformation rather than on linear peptide sequence. KI95 represents the shortest active U94 fragment that preserves biological function, with critical residues likely located within the β-sheet region. These findings highlight the importance of structural integrity in U94 functionality and suggest KI95 as a potential therapeutic agent for cancer treatment.